Oral monthly ibandronate in postmenopausal osteoporosis: Rationale and design of the mobile study

被引：0
|
作者：
Cooper, C
Delmas, PD
Coutant, K
Bonvoisin, B
Recker, RR
机构：
[1] Southampton Gen Hosp, Southampton SO9 4XY, Hants, England
[2] Univ Lyon 1, F-69365 Lyon, France
[3] INSERM, Res Unit 403, Lyon, France
[4] Creighton Univ, Omaha, NE 68178 USA
[5] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
来源：
OSTEOPOROSIS INTERNATIONAL | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [1] Oral monthly ibandronate: Rationale and clinical potential in postmenopausal osteoporosis
    Reginster, JY
    McClung, M
    Coutant, K
    Bonvoisin, B
    Schimmer, RC
    Delmas, PD
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 510 - 510
  • [2] The monthly oral therapy with ibandronate for osteoporosis intervention (motion) study: Rationale and design
    Boonen, S.
    Cooper, C.
    Hadji, P.
    Mahoney, P.
    El Azzouzi, B.
    Masanauskaite, D.
    Delmas, P. D.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S68 - S68
  • [3] Rationale and design of the MOTION study (monthly oral therapy with ibandronate for osteoporosis intervention).
    Cosman, F
    McClung, MR
    Rosen, CJ
    Epstein, S
    Devas, V
    El Azzouzi, B
    Bonvoisin, B
    Zanchetta, J
    Cooper, C
    Delmas, PD
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S398 - S398
  • [4] Once-monthly oral ibandronate versus weekly oral alendronate in postmenopausal osteoporosis: Rationale and design of motion
    Epstein, S.
    Borges, J. L. C.
    Mautalen, C.
    Gonzalez Macias, J.
    Mahoney, P.
    El Azzouzi, B.
    Masanauskaite, D.
    Cosman, F.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S252 - S252
  • [5] Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study
    Miller, PD
    McClung, MR
    Macovei, LV
    Stakkestad, JA
    Luckey, M
    Bonvoisin, B
    Reginster, JY
    Recker, RR
    Hughes, C
    Lewiecki, EM
    Felsenberg, D
    Delmas, PD
    Kendler, DL
    Bolognese, MA
    Mairon, N
    Cooper, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (08) : 1315 - 1322
  • [6] Tolerability of monthly oral ibandronate in postmenopausal osteoporosis: 1-year results from the MOBILE study
    Recker, RR
    Silverman, SL
    Kendler, DL
    Dumont, E
    Hughes, BBC
    Reginster, JY
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S293 - S294
  • [7] Two-year efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: The mobile study
    Cooper, C
    Delmas, PD
    Felsenberg, D
    Hughes, C
    Mairon, N
    Bonvoisin, B
    Reginster, JY
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 68 - 68
  • [8] Monthly oral ibandronate is at least as effective as oral daily ibandronate in postmenopausal osteoporosis: 1-Year results from MOBILE.
    Miller, PD
    Drezner, HK
    Delmas, PD
    Stakkestad, JA
    Hughes, C
    Bonvoisin, B
    Reginster, JY
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S94 - S94
  • [9] Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study
    Reginster, JY
    Adami, S
    Lakatos, P
    Greenwald, M
    Stepan, JJ
    Silverman, SL
    Christiansen, C
    Rowell, L
    Mairon, N
    Bonvoisin, B
    Drezner, MK
    Emkey, R
    Felsenberg, D
    Cooper, C
    Delmas, PD
    Miller, PD
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (05) : 654 - 661
  • [10] A new dosing concept for bisphosphonate therapy: Rationale and design for the Monthly Oral iBandronate in LadiEs (MOBILE) study.
    Recker, RR
    Reginster, JY
    Delmas, PD
    Coutant, K
    Bonvoisin, B
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S261 - S261
12345